PD‑1/PD‑L1 blockade, a novel strategy for targeting metastatic colorectal cancer: A systematic review and meta‑analysis of randomized trials-Reference-Cited by-同舟云学术

PD‑1/PD‑L1 blockade, a novel strategy for targeting metastatic colorectal cancer: A systematic review and meta‑analysis of randomized trials

Published:2022-02-23 Issue:4 Volume:23 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Rotundo Maria¹,Bagnardi Vincenzo²,Rotundo Miryam³,Comandè Mario¹,Zampino Maria⁴

Affiliation:

1. Complex Operative Unit of Medical Oncology, Uboldo Hospital, Cernusco Sul Naviglio, I‑20063 Milan, Italy

2. Department of Statistics and Quantitative Methods, University of Milan‑Bicocca, I‑20126 Milan, Italy

3. Department of Experimental and Clinical Medicine‑Medical, Veterinary and Pharmaceutical Biotechnologies, Magna Graecia University of Catanzaro, I‑88100 Catanzaro, Italy

4. Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico, I‑20141 Milan, Italy

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Reference75 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Van Cutsem;Ann Oncol,2014

3. Diagnosis and treatment of metastatic colorectal cancer: A review;Biller;JAMA,2021

4. Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer;Scheithauer;BMJ,1993

5. Current landscape and future of dual anti-CTLA4 and PD-1/PD-L1 blockade immunotherapy in cancer: Lessons learned from clinical trials with melanoma and non-small cell lung cancer (NSCLC);Chae;J Immunother Cancer,2018

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune checkpoint inhibitors in gastrointestinal malignancies: an Umbrella review;Cancer Cell International;2024-01-05

2. Efficacy and Safety of Bevacizumab and Chemotherapy in Combination with Atezolizumab in Patients with Metastatic Colorectal Cancer: A Meta-Analysis of Randomized Controlled Trials;J BIOL REG HOMEOS AG;2023